Detailed View
DOC - Healthpeak Properties, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
1Y Price Chart
Company Summary
Healthpeak Properties is a real estate investment trust (REIT) that owns and operates a portfolio of life science lab buildings, medical office buildings, and continuing care retirement communities (CCRCs) under the Continuing Care Retirement Community brand. Its primary assets are laboratory and research facilities leased to pharmaceutical, biotech, and medical device tenants on long-term triple-net or gross leases, alongside outpatient medical office space leased to physician groups and health systems. The business model is institutional landlord with recurring rental income, primarily serving healthcare and life sciences tenants in major U.S. cluster markets including San Francisco, San Diego, Boston, and Denver. Healthpeak generates approximately $2.2B in annual revenue, operating exclusively in the United States.
Past Year Trends
- Healthpeak Properties completed the Janus Living senior housing spin-off via IPO in March 2026, generating $880 million in net proceeds and contributing 34 communities to the new platform, reshaping DOC's portfolio mix and capital structure. (Bullish)
- Life science portfolio occupancy declined to 77.7% as of Q1 2026, driven by elevated lab vacancies in Bay Area, Boston, and San Diego submarkets, creating a year-over-year drag on segment NOI despite 1.5 million square feet of lab leasing executed across full-year 2025. (Bearish)
- DOC formed a joint venture with Blackstone in March 2026, contributing a six-property, 100%-occupied outpatient medical portfolio valued at $212 million at a 6.1% cap rate and generating $170 million in proceeds, establishing a capital recycling template for further portfolio monetization. (Bullish)
Next Year Trends
- Approximately 400,000 square feet of lab lease expirations are scheduled in 2026, partially offset by 500,000 square feet of anticipated commencements, with two specific tenants expected to vacate in Q2–Q3 2026; successful absorption of these expirations is the primary determinant of whether life science NOI stabilizes or declines further. (Bearish)
- Janus Living's $880 million IPO cash balance is under deployment toward approximately $400 million of identified senior housing acquisitions, with management projecting a $0.04 per-share FFO accretion benefit once proceeds are fully invested, expected to turn accretive in 2027. (Bullish)
- CommonSpirit Health, a top tenant representing significant outpatient medical NOI, executed early lease renewals in 2026 with 8+ years of additional term on leases originally expiring 2026–2028, reducing near-term rollover risk in DOC's 37-million-square-foot outpatient medical segment. (Bullish)
Red Flags
No severe red flags identified as of August 2025.
Updated 2026-05-21
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 752,952,000 | 199,656,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 719,402,000 | 121,792,000 |
| 2025-09-30 | 10-Q | 2025 | 705,873,000 | -109,848,000 |
| 2025-06-30 | 10-Q | 2025 | 694,348,000 | 39,019,000 |
| 2025-03-31 | 10-Q | 2025 | 702,889,000 | 50,064,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 697,988,000 | 371,575,000 |
| 2024-09-30 | 10-Q | 2024 | 700,397,000 | 346,885,000 |
| 2024-06-30 | 10-Q | 2024 | 695,504,000 | 371,660,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.